CA
NZ
UK
AU
IND
US
The discussion around expanding Medicare to include catastrophic coverage is intensifying, fueled by widespread concerns about the rising rate of personal bankruptcies linked to healthcare expenses. Advocates argue that the current Medicare framework insufficiently protects patients from the economic fallout of serious medical issues, …
Biodexa Pharmaceuticals PLC has made significant strides in its Phase 3 trial for treatments targeting Familial Adenomatous Polyposis (FAP), achieving recruitment of 87 out of a planned 168 subjects. This represents over 50% of the target enrollment, illustrating the company's strong progress in a …
Cardinal Health, Inc. (NYSE: CAH), a leading medical distributor operating with a marketCapitalizationof $54.7 billion, reported impressive results, showcasing revenue of $254.25 billion for the recent fiscal quarter. The revenue reflects a strong year-over-year increase of 14.2%, signaling strongDemandfueled by the company's focus on …
Eli Lilly and Johnson & Johnson are experiencing notable gains, propelled by positive results from their latest clinical studies that have caught the attention of investors. The emerging data suggests potential breakthroughs in their drug pipelines, reflecting advancements in healthcare innovation. This surge comes …
Eli Lilly secured critical European approval for its latest weight loss pill, marking a significant gain in the competitive obesity treatment market. This approval equips Lilly to challenge leading competitor Novo Nordisk, which has previously dominated oral obesity medications. The swift entry into Europe …
Hims & Hers CEO Andrew Dudum defended his company against a lawsuit filed by the Federal Trade Commission (FTC), arguing that the legal action misrepresents the business's operational model. According to Dudum, the lawsuit reveals a fundamental misunderstanding of how Hims & Hers functions …
Kristy Layden's decision to leave her corporate career behind in pursuit of nursing school marks a significant shift amid mounting job market pressures. After being laid off as a senior manager in e-commerce at a large retailer, Layden struggled for over a year to …
Alcon Inc. (NYSE: ALC), a global leader in medical specialties focused on eye care, commands a market capitalization of $37.14 billion. The company specializes in innovative surgical vision products and consumer vision care solutions. Currently, its shares closed at $73.55 each, but recent trading …
BioNTech shares are trading sharply higher, up about 19.64 percent to $110.97, driven by a broad rally across mRNA and oncology-focused biotech names after Moderna and Merck reported a positive late-stage trial result for their jointly developed mRNA cancer therapy in melanoma patients. The …
Maravai LifeSciences shares are trading sharply higher, up about 28.57 percent to $7.38 and touching a fresh 52-week high of $7.70 during the session. Notably, no new macro, sector, or company-specific catalyst has been identified to explain today's move as of this writing, an …
Please wait processing your request...